While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most
A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may predict recurrence of non-functional pancreatic neuroendocrine tumors (pNETs), which do not
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok